Package 63323-300-30

{"route": ["INTRAVENOUS"], "spl_id": "25123257-e41e-420d-9735-74fc71840b6c", "openfda": {"unii": ["UXA545ABTT", "M98T69Q7HP"], "rxcui": ["1659131", "1659137", "1659149"], "spl_set_id": ["fc4d1e35-23eb-4654-8691-ae5bfd50a48a"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL in 1 BOX (63323-300-30)  / 15 mL in 1 VIAL", "package_ndc": "63323-300-30", "marketing_start_date": "20091013"}], "brand_name": "Piperacillin and Tazobactam", "product_id": "63323-300_25123257-e41e-420d-9735-74fc71840b6c", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Penicillin-class Antibacterial [EPC]", "Penicillins [CS]", "beta Lactamase Inhibitor [EPC]", "beta Lactamase Inhibitors [MoA]"], "product_ndc": "63323-300", "generic_name": "PIPERACILLIN SODIUM,TAZOBACTAM SODIUM", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Piperacillin and Tazobactam", "active_ingredients": [{"name": "PIPERACILLIN SODIUM", "strength": "3 g/15mL"}, {"name": "TAZOBACTAM SODIUM", "strength": ".375 g/15mL"}], "application_number": "ANDA065523", "marketing_category": "ANDA", "marketing_start_date": "20091013", "listing_expiration_date": "20261231"}